Cargando…
COVID-19-Induced Thrombosis in Patients without Gastrointestinal Symptoms and Elevated Fecal Calprotectin: Hypothesis Regarding Mechanism of Intestinal Damage Associated with COVID-19
Background: Patients with coronavirus infectious disease 2019 (COVID-19) and gastrointestinal symptoms showed increased values of fecal calprotectin (FC). Additionally, bowel abnormalities were a common finding during abdominal imaging of individuals with COVID-19 despite being asymptomatic. The cur...
Autores principales: | Giuffrè, Mauro, Di Bella, Stefano, Sambataro, Gianluca, Zerbato, Verena, Cavallaro, Marco, Occhipinti, Alessandro Agostino, Palermo, Andrea, Crescenzi, Anna, Monica, Fabio, Luzzati, Roberto, Crocè, Lory Saveria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557761/ https://www.ncbi.nlm.nih.gov/pubmed/32947803 http://dx.doi.org/10.3390/tropicalmed5030147 |
Ejemplares similares
-
High fecal calprotectin levels are associated with SARS-CoV-2 intestinal shedding in COVID-19 patients: A proof-of-concept study
por: Zerbato, Verena, et al.
Publicado: (2021) -
Calprotectin and SARS-CoV-2: A Brief-Report of the Current Literature
por: Giuffrè, Mauro, et al.
Publicado: (2021) -
Spontaneous Rectal Perforation in a Patient with SARS–CoV-2 Infection
por: Giuffrè, Mauro, et al.
Publicado: (2020) -
COVID-19 and intestinal inflammation: Role of fecal calprotectin
por: Ojetti, Veronica, et al.
Publicado: (2020) -
The Usefulness of Fecal Calprotectin in the era of the COVID-19 Pandemic
por: Mago, Sheena, et al.
Publicado: (2021)